Funding Collaborations FAST actively funds research across the drug development spectrum and maintains rolling grant applications, presenting multiple touchpoints for partnerships, co-funding opportunities, and translational research collaborations with biotech firms and academic centers.

Strategic Partnerships Recent press indicates FAST forging collaborations with biotech companies such as Apertura Gene Therapy for blood-brain barrier crossingCapsids, signaling openness to alliance models that can expand therapeutic delivery platforms and accelerate program timelines.

Rare Disease Focus FAST specializes in Angelman syndrome and has a track record of substantial philanthropic funding, including significant gifts to research centers, suggesting opportunities to align with rare-disease programs, orphan drug development teams, and CNS-focused ventures.

Global Research Network As the largest non-governmental funder in its field and with partnerships across universities and biotech, FAST offers a gateway to a broad research ecosystem, enabling access to investigators, trials, and translational infrastructure for joint ventures.

Technology Enablement Utilizing a mature tech stack (AWS, WordPress, collaboration tools) and active outreach channels (email, social, CRM-like tools), FAST demonstrates readiness for scalable program management, donor engagement, and project coordination platforms that can be leveraged in joint programs.